US SB4672 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on September 23 2020 - 25% progression, died in committee
Action: 2020-09-23 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5835)
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 23 2020 - 25% progression, died in committee
Action: 2020-09-23 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5835)
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies. Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the field of regenerative medicine using adult stem cells. In addition, the Government Accountability Office must examine various issues related to the national blood stem cell workforce.
Title
TRANSPLANT Act of 2020 Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020
Sponsors
Sen. Jack Reed [D-RI] | Sen. Richard Burr [R-NC] | Sen. Tina Smith [D-MN] | Sen. Tim Scott [R-SC] |
History
Date | Chamber | Action |
---|---|---|
2020-09-23 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5835) |
Same As/Similar To
HB3520 (Related) 2019-06-27 - Referred to the Subcommittee on Health.
HB4764 (Related) 2020-12-14 - Message on Senate action sent to the House.
HB4764 (Related) 2020-12-14 - Message on Senate action sent to the House.
Subjects
Advisory bodies
Blood and blood diseases
Cell biology and embryology
Congressional oversight
Government studies and investigations
Health
Health programs administration and funding
Medical research
Organ and tissue donation and transplantation
Research administration and funding
Blood and blood diseases
Cell biology and embryology
Congressional oversight
Government studies and investigations
Health
Health programs administration and funding
Medical research
Organ and tissue donation and transplantation
Research administration and funding
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/4672/all-info |
Text | https://www.congress.gov/116/bills/s4672/BILLS-116s4672is.pdf |